Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference38 articles.
1. World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. 2002 [cited 2016 Dec 1].
http://apps.who.int/medicinedocs/en/d/Js4893e/
.
2. US Food and Drug Administration. FDA adverse events reporting system (FAERS). 2016. [cited 2016 Feb 25].
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/UCM082196
.
3. Ishiguro C, Hall M, Neyarapally GA, Dal PG. Post-market drug safety evidence sources: an analysis of FDA drug safety communications. Pharmacoepidemiol Drug Saf. 2012;21(10):1134–6.
4. van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients; an 11-country survey. Drug Saf. 2012;35(1):45–60.
5. The EU pharmacovigilance system. 2012 [cited 2016 Feb 17].
http://ec.europa.eu/health/human-use/pharmacovigilance/index_en.htm
.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献